Repurposing of Human Kinase Inhibitors in Neglected Protozoan Diseases.

Abstract:

:Human African trypanosomiasis (HAT), Chagas disease, and leishmaniasis belong to a group of infectious diseases known as neglected tropical diseases and are induced by infection with protozoan parasites named trypanosomatids. Drugs in current use have several limitations, and therefore new candidate drugs are required. The majority of current therapeutic trypanosomatid targets are enzymes or cell-surface receptors. Among these, eukaryotic protein kinases are a major group of protein targets whose modulation may be beneficial for the treatment of neglected tropical protozoan diseases. This review summarizes the finding of new hit compounds for neglected tropical protozoan diseases, by repurposing known human kinase inhibitors on trypanosomatids. Kinase inhibitors are grouped by human kinase family and discussed according to the screening (target-based or phenotypic) reported for these compounds on trypanosomatids. This collection aims to provide insight into repurposed human kinase inhibitors and their importance in the development of new chemical entities with potential beneficial effects on the diseases caused by trypanosomatids.

journal_name

ChemMedChem

journal_title

ChemMedChem

authors

Dichiara M,Marrazzo A,Prezzavento O,Collina S,Rescifina A,Amata E

doi

10.1002/cmdc.201700259

subject

Has Abstract

pub_date

2017-08-22 00:00:00

pages

1235-1253

issue

16

eissn

1860-7179

issn

1860-7187

journal_volume

12

pub_type

杂志文章,评审
  • The potential of P1 site alterations in peptidomimetic protease inhibitors as suggested by virtual screening and explored by the use of C-C-coupling reagents.

    abstract::A synthetic concept is presented that allows the construction of peptide isostere libraries through polymer-supported C-acylation reactions. A phosphorane linker reagent is used as a carbanion equivalent; by employing MSNT as a coupling reagent, the C-acylation can be conducted without racemization. Diastereoselective...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200500027

    authors: Weik S,Luksch T,Evers A,Böttcher J,Sotriffer CA,Hasilik A,Löffler HG,Klebe G,Rademann J

    更新日期:2006-04-01 00:00:00

  • The 12th AFMC International Medicinal Chemistry Symposium (AIMECS 2019) in Istanbul, Turkey.

    abstract::AFMC-AIMECS meetings are internationally organized biannually by the Asian Federation for Medicinal Chemistry (AFMC) and are focused on recent studies in drug discovery and development both in academia and industry. Member organizations of the AFMC are the Pharmaceutical Society of Japan, the Chinese Pharmaceutical As...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201900623

    authors: Olgac A,Yalcin I,Aki-Yalcin E

    更新日期:2020-01-07 00:00:00

  • Structure-activity relationship studies of 3-aroylindoles as potent antimitotic agents.

    abstract::The concise synthesis and structure-activity relationship (SAR) studies of 3-aroylindoles were carried out in an effort to improve the potency and solubility of anticancer drug candidate BPR0L075 (8) by exploring structure modifications through three regimens: substitution of the B ring, at the N1 position, and of the...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200600125

    authors: Liou JP,Mahindroo N,Chang CW,Guo FM,Lee SW,Tan UK,Yeh TK,Kuo CC,Chang YW,Lu PH,Tung YS,Lin KT,Chang JY,Hsieh HP

    更新日期:2006-10-01 00:00:00

  • 11 C Radiolabeling of anle253b: a Putative PET Tracer for Parkinson's Disease That Binds to α-Synuclein Fibrils in vitro and Crosses the Blood-Brain Barrier.

    abstract::There is an urgent clinical need for imaging of α-synuclein (αSyn) fibrils, the hallmark biomarker for Parkinson's disease, in neurodegenerative disorders. Despite immense efforts, promising tracer candidates for nuclear imaging of αSyn are rare. Diphenyl pyrazoles are known modulators of αSyn aggregation and thus bea...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201900689

    authors: Maurer A,Leonov A,Ryazanov S,Herfert K,Kuebler L,Buss S,Schmidt F,Weckbecker D,Linder R,Bender D,Giese A,Pichler BJ,Griesinger C

    更新日期:2020-03-05 00:00:00

  • A glucose derivative as natural alternative to the cyclohexane-1,2-diamine ligand in the anticancer drug oxaliplatin?

    abstract::Having oxaliplatin as archetype, several platinum complexes with a carbohydrate moiety resembling the cyclohexane-1,2-diamine ligand of oxaliplatin have been prepared. As leaving groups, the anionic ligands iodide, oxalate, and malonate were utilized, and for comparison purposes the chloro complex was employed. All co...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200600279

    authors: Berger I,Nazarov AA,Hartinger CG,Groessl M,Valiahdi SM,Jakupec MA,Keppler BK

    更新日期:2007-04-01 00:00:00

  • Understanding of molecular substructures that contribute to hERG K+ channel blockade: synthesis and biological evaluation of E-4031 analogues.

    abstract::Cardiotoxicity is a common side effect of a large variety of drugs that is often caused by off-target human ether-à-go-go-related gene (hERG) potassium channel blockade. In this study, we designed and synthesized a series of derivatives of the class III antiarrhythmic agent E-4031. These compounds where evaluated in a...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201100366

    authors: Vilums M,Overman J,Klaasse E,Scheel O,Brussee J,IJzerman AP

    更新日期:2012-01-02 00:00:00

  • Cyclic RGD-containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting.

    abstract::Cyclic RGD-containing functionalized azabicycloalkane peptides were synthesized with the aim of developing high-affinity selective integrin ligands as carriers for therapeutic and diagnostic purposes. Herein we describe the synthesis and in vitro screening of these RGD derivatives, as well as the determination of thei...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200800422

    authors: Manzoni L,Belvisi L,Arosio D,Civera M,Pilkington-Miksa M,Potenza D,Caprini A,Araldi EM,Monferini E,Mancino M,Podestà F,Scolastico C

    更新日期:2009-04-01 00:00:00

  • Design, synthesis, and structure-activity relationships of 3,4,5-trisubstituted 4,5-dihydro-1,2,4-oxadiazoles as TGR5 agonists.

    abstract::Given its role in the mediation of energy and glucose homeostasis, the G-protein-coupled bile acid receptor 1 (TGR5) is considered a potential target for the treatment of type 2 diabetes mellitus and other metabolic disorders. By thorough analysis of diverse structures of published TGR5 agonists, a hypothetical ligand...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201300144

    authors: Zhu J,Ye Y,Ning M,Mándi A,Feng Y,Zou Q,Kurtán T,Leng Y,Shen J

    更新日期:2013-07-01 00:00:00

  • Preparation and Evaluation of Potent Pentafluorosulfanyl-Substituted Anti-Tuberculosis Compounds.

    abstract::The global fight to stop tuberculosis (TB) remains a great challenge, particularly with the increase in drug-resistant strains and a lack of funding to support the development of new treatments. To bolster a precarious drug pipeline, we prepared a focused panel of eight pentafluorosulfanyl (SF5 ) compounds which were ...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201700170

    authors: Moraski GC,Bristol R,Seeger N,Boshoff HI,Tsang PS,Miller MJ

    更新日期:2017-07-20 00:00:00

  • CHIPMUNK: A Virtual Synthesizable Small-Molecule Library for Medicinal Chemistry, Exploitable for Protein-Protein Interaction Modulators.

    abstract::A common issue during drug design and development is the discovery of novel scaffolds for protein targets. On the one hand the chemical space of purchasable compounds is rather limited; on the other hand artificially generated molecules suffer from a grave lack of accessibility in practice. Therefore, we generated a n...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201700689

    authors: Humbeck L,Weigang S,Schäfer T,Mutzel P,Koch O

    更新日期:2018-03-20 00:00:00

  • Design, synthesis, and preliminary biological evaluation of pyrrolo[3,4-c]quinolin-1-one and oxoisoindoline derivatives as aggrecanase inhibitors.

    abstract::A small set of aggrecanase inhibitors based on the pyrrolo[3,4-c]quinolin-1-one or oxoisoindoline frameworks bearing a 4-(benzyloxy)phenyl substituent and different zinc binding groups were rationally designed and evaluated in silico by docking studies using the crystal structure of the ADAMTS-5 catalytic domain (PDB ...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200900523

    authors: Cappelli A,Nannicini C,Valenti S,Giuliani G,Anzini M,Mennuni L,Giordani A,Caselli G,Stasi LP,Makovec F,Giorgi G,Vomero S

    更新日期:2010-05-03 00:00:00

  • 6,7-Dimethoxy-2-{2-[4-(1H-1,2,3-triazol-1-yl)phenyl]ethyl}-1,2,3,4-tetrahydroisoquinolines as superior reversal agents for P-glycoprotein-mediated multidrug resistance.

    abstract::P-glycoprotein (P-gp)-mediated multidrug resistance (MDR) is a major obstacle for successful cancer chemotherapy. Based on our previous study, 17 novel compounds with the 6,7-dimethoxy-2-{2-[4-(1H-1,2,3-triazol-1-yl)phenyl]ethyl}-1,2,3,4-tetrahydroisoquinoline scaffold were designed and synthesized. Among them, 2-[(1-...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201402463

    authors: Liu B,Qiu Q,Zhao T,Jiao L,Li Y,Huang W,Qian H

    更新日期:2015-02-01 00:00:00

  • Comparative Pharmacological Study of Common NMDA Receptor Open Channel Blockers Regarding Their Affinity and Functional Activity toward GluN2A and GluN2B NMDA Receptors.

    abstract::Because only a few studies have investigated the affinity and functional activity of NMDA receptor open channel blockers under the same assay conditions, a comparative study of common open channel blockers is of major interest. The pharmacological activities of MK-801, phencyclidine (PCP), dexoxadrol, etoxadrol, (S)- ...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201700810

    authors: Temme L,Schepmann D,Schreiber JA,Frehland B,Wünsch B

    更新日期:2018-03-06 00:00:00

  • Probing Ligand Structure-Activity Relationships in Pregnane X Receptor (PXR): Efavirenz and 8-Hydroxyefavirenz Exhibit Divergence in Activation.

    abstract::Efavirenz (EFV), an antiretroviral that interacts clinically with co-administered drugs via activation of the pregnane X receptor (PXR), is extensively metabolized by the cytochromes P450. We tested whether its primary metabolite, 8-hydroxyEFV (8-OHEFV) can activate PXR and potentially contribute to PXR-mediated drug-...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201700730

    authors: Narayanan B,Lade JM,Heck CJS,Dietz KD,Wade H,Bumpus NN

    更新日期:2018-04-06 00:00:00

  • 16-Membered Macrolide Lactone Derivatives Bearing a Triazole-Functionalized Arm at the Aglycone C13 Position as Antibacterial and Anticancer Agents.

    abstract::A series of new C13-triazole-bridged and C13-ether leucomycin analogues with a reduced aldehyde group were synthesized. Derivatives with the highest antibacterial [MIC values (S. epidermidis, S. pneumoniae): ∼2-4 μg mL(-1) ; 2.55-5.09 μm] and cytotoxic [IC50 values (HeLa, KB, MCF-7, A549, HepG2 cells): ∼1.35-3.70 μm] ...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201600250

    authors: Domagalska J,Janas A,Pyta K,Pecyna P,Ruszkowski P,Celewicz L,Gajecka M,Bartl F,Przybylski P

    更新日期:2016-09-06 00:00:00

  • Development of Novel Inhibitors for Histone Methyltransferase SET7/9 based on Cyproheptadine.

    abstract::The histone methyltransferase SET7/9 methylates not only histone but also non-histone proteins as substrates, and therefore, SET7/9 inhibitors are considered candidates for the treatment of diseases. Previously, our group identified cyproheptadine, used clinically as a serotonin receptor antagonist and histamine recep...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201800233

    authors: Hirano T,Fujiwara T,Niwa H,Hirano M,Ohira K,Okazaki Y,Sato S,Umehara T,Maemoto Y,Ito A,Yoshida M,Kagechika H

    更新日期:2018-08-10 00:00:00

  • Efficient stacking on protein amide fragments.

    abstract::The less polar π-surface of protein amide groups is exposed in many receptor binding sites, either as part of the backbone or in Gln/Asn side chains. Using quantum chemical calculations and Protein Data Bank (PDB) searches on model systems, we investigate the energetics and geometric preferences for the stacking on am...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201200512

    authors: Harder M,Kuhn B,Diederich F

    更新日期:2013-03-01 00:00:00

  • Targeting an Aromatic Hotspot in Plasmodium falciparum 1-Deoxy-d-xylulose-5-phosphate Reductoisomerase with β-Arylpropyl Analogues of Fosmidomycin.

    abstract::Blocking the 2-C-methyl-d-erythrithol-4-phosphate pathway for isoprenoid biosynthesis offers new ways to inhibit the growth of Plasmodium spp. Fosmidomycin [(3-(N-hydroxyformamido)propyl)phosphonic acid, 1] and its acetyl homologue FR-900098 [(3-(N-hydroxyacetamido)propyl)phosphonic acid, 2] potently inhibit 1-deoxy-d...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201600249

    authors: Sooriyaarachchi S,Chofor R,Risseeuw MD,Bergfors T,Pouyez J,Dowd CS,Maes L,Wouters J,Jones TA,Van Calenbergh S,Mowbray SL

    更新日期:2016-09-20 00:00:00

  • Facile identification of dual FLT3-Aurora A inhibitors: a computer-guided drug design approach.

    abstract::Computer-guided drug design is a powerful tool for drug discovery. Herein we disclose the use of this approach for the discovery of dual FMS-like receptor tyrosine kinase-3 (FLT3)-Aurora A inhibitors against cancer. An Aurora hit compound was selected as a starting point, from which 288 virtual molecules were screened...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201300571

    authors: Chang Hsu Y,Ke YY,Shiao HY,Lee CC,Lin WH,Chen CH,Yen KJ,Hsu JT,Chang C,Hsieh HP

    更新日期:2014-05-01 00:00:00

  • Asymmetric synthesis and biological evaluation of glycosidic prodrugs for a selective cancer therapy.

    abstract::A severe limitation in cancer therapy is the often insufficient differentiation between malign and benign tissue using known chemotherapeutics. One approach to decrease side effects is antibody-directed enzyme prodrug therapy (ADEPT). We have developed new glycosidic prodrugs such as (-)-(1S)-26 b based on the antibio...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200800250

    authors: Tietze LF,von Hof JM,Krewer B,Müller M,Major F,Schuster HJ,Schuberth I,Alves F

    更新日期:2008-12-01 00:00:00

  • Chemistry and biological activity of platinum amidine complexes.

    abstract::Platinum amidine complexes represent a new class of potential antitumor drugs that contain the imino moiety HN=C(sp(2)) bonded to the platinum center. They can be related to the iminoether derivatives, which were recently shown to be the first Pt(II) compounds with a trans configuration endowed with anticancer activit...

    journal_title:ChemMedChem

    pub_type: 杂志文章,评审

    doi:10.1002/cmdc.201100150

    authors: Michelin RA,Sgarbossa P,Sbovata SM,Gandin V,Marzano C,Bertani R

    更新日期:2011-07-04 00:00:00

  • Discovery of isoerianin analogues as promising anticancer agents.

    abstract::The cytotoxic activity of a series of 23 new isoerianin derivatives with modifications on both the A and B rings was studied. Several compounds exhibited excellent antiproliferative activity at nanomolar concentrations against a panel of human cancer cell lines. The most cytotoxic compound, isoerianin (3), strongly in...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201000456

    authors: Messaoudi S,Hamze A,Provot O,Tréguier B,Rodrigo De Losada J,Bignon J,Liu JM,Wdzieczak-Bakala J,Thoret S,Dubois J,Brion JD,Alami M

    更新日期:2011-03-07 00:00:00

  • Cis-Configured aziridines are new pseudo-irreversible dual-mode inhibitors of Candida albicans secreted aspartic protease 2.

    abstract::A series of cis-configured epoxides and aziridines containing hydrophobic moieties and amino acid esters were synthesized as new potential inhibitors of the secreted aspartic protease 2 (SAP2) of Candida albicans. Enzyme assays revealed the N-benzyl-3-phenyl-substituted aziridines 11 and 17 as the most potent inhibito...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200700101

    authors: Degel B,Staib P,Rohrer S,Scheiber J,Martina E,Büchold C,Baumann K,Morschhäuser J,Schirmeister T

    更新日期:2008-02-01 00:00:00

  • Phenylboronic Acid Derivatives as Validated Leads Active in Clinical Strains Overexpressing KPC-2: A Step against Bacterial Resistance.

    abstract::The emergence and dissemination of multidrug resistant (MDR) pathogens resistant to nearly all available antibiotics poses a significant threat in clinical therapy. Among them, Klebsiella pneumoniae clinical isolates overexpressing KPC-2 carbapenemase are the most worrisome, extending bacterial resistance to last-reso...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201700788

    authors: Celenza G,Vicario M,Bellio P,Linciano P,Perilli M,Oliver A,Blazquez J,Cendron L,Tondi D

    更新日期:2018-04-06 00:00:00

  • Trifluoromethyl Dihydrothiazine-Based β-Secretase (BACE1) Inhibitors with Robust Central β-Amyloid Reduction and Minimal Covalent Binding Burden.

    abstract::The β-site amyloid precursor protein cleaving enzyme 1 (BACE1, also known as β-secretase) is a promising target for the treatment of Alzheimer's disease. A pKa lowering approach over the initial leads was adopted to mitigate hERG inhibition and P-gp efflux, leading to the design of 6-CF3 dihydrothiazine 8 (N-(3-((4S,6...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201900478

    authors: Anan K,Iso Y,Oguma T,Nakahara K,Suzuki S,Yamamoto T,Matsuoka E,Ito H,Sakaguchi G,Ando S,Morimoto K,Kanegawa N,Kido Y,Kawachi T,Fukushima T,Teisman A,Urmaliya V,Dhuyvetter D,Borghys H,Austin N,Van Den Bergh A,Ver

    更新日期:2019-11-20 00:00:00

  • Selective inhibitors of the protein tyrosine phosphatase SHP2 block cellular motility and growth of cancer cells in vitro and in vivo.

    abstract::Selective inhibitors of the protein tyrosine phosphatase SHP2 (src homology region 2 domain phosphatase; PTPN11), an enzyme that is deregulated in numerous human tumors, were generated through a combination of chemical synthesis and structure-based rational design. Seventy pyridazolon-4-ylidenehydrazinyl benzenesulfon...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201500015

    authors: Grosskopf S,Eckert C,Arkona C,Radetzki S,Böhm K,Heinemann U,Wolber G,von Kries JP,Birchmeier W,Rademann J

    更新日期:2015-05-01 00:00:00

  • 50 Years European Federation for Medicinal Chemistry (EFMC) - The Ascent of Medicinal Chemistry in Europe.

    abstract::A historical overview of key events that led, 50 years ago, to the foundation of the European Federation for Medicinal Chemistry (EFMC), and the impact this had on promoting and structuring medicinal chemistry as a discipline in Europe. EFMC, together with the growing number of newly established national medicinal che...

    journal_title:ChemMedChem

    pub_type: 社论

    doi:10.1002/cmdc.202000691

    authors: Differding E

    更新日期:2020-12-15 00:00:00

  • Synthesis and biological evaluation of bicyclic nucleosides as inhibitors of M. tuberculosis thymidylate kinase.

    abstract::Herein we describe the synthesis and conformational analysis of a series of bicyclic thymidine derivatives and their evaluation as inhibitors of thymidine monophosphate kinase from Mycobacterium tuberculosis (TMPKmt), based on previously discovered bicyclic sugar nucleosides. With a K(i) value of 2.3 microm, 1-[3-amin...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200600028

    authors: Van Daele I,Munier-Lehmann H,Hendrickx PM,Marchal G,Chavarot P,Froeyen M,Qing L,Martins JC,Van Calenbergh S

    更新日期:2006-10-01 00:00:00

  • A Novel Prodrug of a γ-Glutamylcyclotransferase Inhibitor Suppresses Cancer Cell Proliferation in vitro and Inhibits Tumor Growth in a Xenograft Mouse Model of Prostate Cancer.

    abstract::γ-Glutamylcyclotransferase (GGCT) depletion inhibits cancer cell proliferation. However, whether the enzymatic activity of GGCT is critical for the regulation of cancer cell growth remains unclear. In this study, a novel diester-type cell-permeable prodrug, pro-GA, was developed based on the structure of N-glutaryl-l-...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201700660

    authors: Ii H,Yoshiya T,Nakata S,Taniguchi K,Hidaka K,Tsuda S,Mochizuki M,Nishiuchi Y,Tsuda Y,Ito K,Kageyama S,Yoshiki T

    更新日期:2018-01-22 00:00:00

  • A Flexible Strategy for Modular Synthesis of Curcuminoid-BF2 /Curcuminoid Pairs and Their Comparative Antiproliferative Activity in Human Cancer Cell Lines.

    abstract::A facile protocol that enables synthetic interconversion of CUR-BF2 and CUR compounds is described that significantly widens the preparative scope of curcuminoids, providing access to larger libraries of compounds, thus enabling comparative antiproliferative and apoptotic study of a larger library of synthetic analogs...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201900640

    authors: Abonia R,Laali KK,Raja Somu D,Bunge SD,Wang EC

    更新日期:2020-02-17 00:00:00